Recent studies demonstrate that signal transducer and activator of transcription 3 (STAT3) plays critical roles in initiation and progression of pancreatic cancer, especially in mutant KRAS-mediated pancreatic ductal adenocarcinomas (PDAC) [8–10]. Here, STAT3 is linked to pancreatic ductal adenocarcinoma.